Healthcare Distribution Alliance – Patients Move Us.

+ About
- Role of Distributors
- Member Directory
- HDA History
- Industry Recognition
- Staff Directory
- Diversity, Equity & Inclusion
- Executive Committee
- Mission
- Board of Directors
- Join HDA
- Councils and Committees
- Careers
- Membership
- About
  
  Information regarding HDA's history, leadership, mission, values and staff.
+ Issues
- COVID-19 Response
- Pharmacy Services Administrative Organizations
- Pharmaceutical Traceability
- Distributor Licensure
- Importation of Prescription Medicines
- Drug Product Availability
- Prescription Drug Abuse and Diversion
- Emergency Preparedness
- Taxes
- Advocacy
- Healthcare Affordability
- Issues
  
  HDA reviews key priority issues and advocates on behalf of its pharmaceutical distributor members for standards, public policies and business processes that ensure a safe and efficient supply chain.
+ Events
- Distribution Management Conference and Expo
- PCSC Educational Seminar
- Business and Leadership Conference
- Webinars
- Annual Board and Membership Meeting
- Speaker Resource Center
- Traceability Seminar
- Events
  
  HDA regularly brings members and key healthcare supply chain stakeholders together to share industry information, learn about best practices, and be introduced to new products and services.
+ News
- Press Releases
- Blog
- Testimony
- HDA in the News
  
  Press releases, public testimony executive statements and information on HDA's efforts on behalf of pharmaceutical distributors and the supply chain.
+ Resources
- Publications
- COVID-19 Response
- Health Delivered
- Professional Development
- Webinars
- PCSC
- Allied Against Opioid Abuse
- Resources
  
  HDA and the HDA Research Foundation produce a variety of resources to enhance the value of the supply chain and increase industry knowledge.

Health Delivered

HDA distributors move billions of vaccines and supplies every year — from the biggest cities to the smallest towns.

Rising to the Challenge of COVID-19

From the early surges of COVID-19 to vaccine distribution, distributors are bringing forward lessons learned of the pandemic response.

Learn More

Support for Ukraine

Learn how HDA member companies and executives are aiding relief efforts.

Learn more

HDA Factbook

An estimated 93 percent of the country’s prescription medicines and healthcare products move through HDA distributors. Get the latest industry trends for fiscal year 2020.

Download

FEATURED UPCOMING EVENTS

2022 Business and Leadership Conference

June 5 to 8, 2022 | JW Marriott Orlando Grande Lakes, Orlando, Fla.

HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators. Exclusive to HDA...

View All Events

MEMBER SPOTLIGHT

McKesson Corporation, currently ranked 5th on the FORTUNE 500, is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care and healthcare information technology.

Learn More

IN THE NEWS

May 12, 2022

Governor Hogan's Signing of Maryland Law Affirms Critical Role of PSAOs and Support for Independent Pharmacies

March 17, 2022

Rx Supply Chain Progressing on EPCIS Adoption for DSCSA, Yet Challenges Still Remain

March 15, 2022

HDA Statement on the PREVENT Pandemics Act

View All News

ISSUES IN DISTRIBUTION

Pharmaceutical Traceability

HDA and the healthcare distribution industry have led on federal traceability issues for nearly two decades. This work culminated in the passage of the Drug Supply Chain Security Act (DSCSA) in 2013. The...

Healthcare Affordability

With HDA distributors providing between $33–$53 billion in cost savings to the U.S. healthcare economy each year, our industry is committed to improving access to lower-cost, high-quality medicines for...

Prescription Drug Abuse and Diversion

HDA and our primary pharmaceutical distributor members are committed to bringing industry and government together to tackle our nation’s complex prescription drug abuse and diversion epidemic, a serious...

Importation of Prescription Medicines

HDA opposes permitting the importation into the U.S. of pharmaceuticals sold or designated for sale in foreign countries. HDA firmly believes that allowing importation increases the likelihood of counterfeit...